Bupropion Hydrochloride
- Product NDC
- 0904-6573
- 11-digit product format
- 009046573
- Labeler code
- 0904
- Product ID
- 0904-6573_6a8a96ee-b20f-4a8f-8b35-8c15ae1ce29f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bupropion Hydrochloride
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Major Pharmaceuticals
- Application
- ANDA077284
- Marketing category
- ANDA
- Marketing start
- 2007-06-12
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0904-6573-04 | 00904657304 | 30 BLISTER PACK in 1 CARTON (0904-6573-04) > 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK | 30 blister pack | 2007-06-12 | 0000-00-00 | No | No | Current |